CN
111.png
banner
Your present location:Home/About us/News/Company/Research progress on SARS-CoV-2

Research progress on SARS-CoV-2

Release date:2021-11-24

Research progress on SARS-CoV-2


Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

SCIENCE26 Oct 2021 First Release DOI: 10.1126/science.abl9463

Abstract

The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously prevalent variants and become a dominant strain worldwide. We report the structure, function, and antigenicity of its full-length spike (S) trimer and those of the Gamma and Kappa variants and compare their characteristics with the G614, Alpha, and Beta variants. Delta S can fuse membranes more efficiently at low levels of cellular receptor ACE2, and its pseudotyped viruses infect target cells substantially faster than the other five variants, possibly accounting for its heightened transmissibility. Each variant shows different rearrangement of the antigenic surface of the N-terminal domain of the S protein, but only causes local changes in the receptor-binding domain (RBD), making the RBD a better target for therapeutic antibodies.

For details, please visit https://www.science.org/doi/10.1126/science.abl9463

Magen’s Viral DNA/RNA products please visit http://www.magen-tec.com/products/list.aspx?lcid=22

Back to list
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

This site uses cookies to improve your online experience,allow you to share content on social media,measure traffic to this website and display customised ads based on your browsing activity.